BSECompany Update3d ago · 22 Sept 2026, 05:37 pm

Intimation of Disclosures

Evexia Lifecare Ltd · 524444

✦ AI SummaryPledge

Evexia Lifecare Ltd has received a disclosure from Shree Saibaba Exim Private Limited, a promoter group entity, regarding the purchase of 14,45,000 equity shares of Evexia Lifecare Limited on September 22, 2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment1/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Attachments (1)

📄

95788310-cb1d-4458-bb68-e577f3d59b1f.pdf

pdf

Download →
View document text
eve:ia EVEXIA LIFECARE LIMITED (Formerly Known as Kavit Industries Ltd.) Date: September 22, 2026 BSE Limited P. ). Towers, Dalal Street, Fort, Mumbai- 400001 Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, In accordance with the provisions of Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has received disclosure on September 22, 2026 from M/s. Shree Saibaba Exim Private Limited, Promoter Group with respect to the purchase of 14,45,000 equity shares of Evexia Lifecare Limited. Please find enclosed herewith necessary disclosure under Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Please take the same on your record. Thanking you. Yours faithfully, For, EVEXIA LIFECAI MANAGING DIRECTOR (DIN: 01631093) EncAsl A.bo:ve Reg. Off. : Tundav Anjesar Raod, Vill. Tundav, Tal.: Savli, Vadodara - 391 775 Corporate Office : 9th Floor, Galav Chambers, Sayajigunj, Vadodara-390 020. Ph : +91 265 2361100 / 2200 CIN : L23100GJ1990PLC014692 Email : info@evexialifecare.com Web.: www.evexialifecare.com Shree Saibaba Exim Private Limited 9™ Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020 CIN - U51101GJ2013PTC077088 Email ID - s! ibabaexim2! il.com Date: September 22, 2026 Managing Director, EVEXIA LIFECARE LIMITED, Vill : Tundao, Tal: Salvi Vadodara- 391775, Gujarat Scrip Code: 524444 Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Dear Sir/Madam, This is with reference to the purchase of equity shares dated September 22, 2026. This intimation is provided in terms of the provisions of Regulation 7(2)(a) of the SEBI Insider Trading Regulations and all other applicable provisions of Securities and Exchange Board of India Act, 1992 and applicable rules and regulations made thereunder. This letter is intended for the Company’s information and records. Thanking You. Director (DIN: 02480296) Encl: As above j|pg x S|oy yunwej oe ju8o oue jo ob |m oi wn do eu y o|mJ uyma tq sx ae |pa 3/dnq ua dx y9 |2 dxn aa |p yaJaun ® oga 1/ o wera h yuqaJ- sa neusj x‘ asods 5&( Zz-0 6o -d |e wg |sd 0w ze 9I xy r I|wuN s i p f e u o ) - ( ) 9 u o n e y w i e a : ( z ) £ m a a ] S T 0 Z ‘ y ( S u r p e l a p i s u j J EAIHXIV TI4EDVH3 TINILAQ ISIN oJ 31 dowdeuA: - NAETEWOT0E0 .EEN eu mvu.:._u_uu 0 J-&0!.2&:»53.. dlowojaJ y.ond‘-ga PUfl fl.G EEA ag Sd odm yg e3a sId Pne Io Lb sA aI pMIL NY a3 SIq Pe ro 3J 1o ib pm gae io sb om usimou syexas‘ )giowoj sdajA wL oAd wo |oj Np Oe d e|ao I jN |u3 %2 9N |LJ ds na od un y4da dxow 1) r4 Jg n ay j0e esa/ s o e2jp BiuB ns dy /e x p|a ss ‘y e 3ras‘ asid uy ep ueMEIL' as pye x a|as‘ u ]ys‘ xys‘ ME I /LB s) o0 uo u /|A aD J0UA21J YIA0 Iu ©jys‘ qnxa JnqI n) o0u A /|2J s/yu rq ua ag pa uq JagauJ yuao on eq |1s rn ea aa sn ‘aas‘ q na oq a /|uj xapep aay r |SyS gnsys 03a1 sn |aas‘ yo/o ra yu aaunpa -dp aes swo (ujs mau“ aa pju Ap |pa 2u (au (q‘ )5E[ giowo |mT uP |T S'Y 0¥ |T mT ' - T0 |6- ns dy 8s $yer ss aye rC aS 8z $02 906- )9'0%# )0°0L9 )9'121 2029 \‘vum/ ) 1 9 3 S nerus oj)ya domudeu qererpso D udI QVN ‘N/ BASS D0 MU N3 B9U 105 1E ‘2Iq eL IA WBNA yraap YVL dI N80ON yaayqss 1) 0y 0e ei so sd ee sd i8le JmS (an AEPOPEIB - €600Z0‘ ynfezeJ LLLVEL WZ O6T9 uejf:syTaoseiqeqeo NWzz@0zW JWa0od u oa d x yn - u+ 6 1 0 7 ‘ s s i o d - p o r e) 9 u o S ) u n J o( 7 1 5 3 0 ] o n p n B a y ( B u u d i s o p - d n o a sn U lE P I U MO N ° s J a q u I n N S P E N U 0 I ) 1 z N p n , 1 a p 1 o j o w o aU A SN N S Eo ( 2 1 2 s a n f e A s d o e z u flo u o n i i o 4 d ) 1 4 3 5 0 J o J a q u i SHEsIoH-YINS-IOHO0-PuE Q J o a x m n g P e n u o n S ) u n J o J a u( 3 2 1 5 1 0 ] + S P ( 1 ) u o n p i n G a u s a p u n p a u i f o p s B u j u p a t i a y 3 4 D Y [ [ D Y S S A H N 2 2 S , ( ) = 1 0 8 s a B a p y p 1 2 1 3 0 A u n / a b p . 1 2 3 0 4 q / 5 9 X D 3 S A P N J I X 2 U O N I D S U D . L ] , o a n o p ( 1 ) A q Aw u e d- m o d2 3 y Jo O S S3 N L Ie N U 0 Se I A Rd I I UP I S u i p je o n s p e z a q S 0 - S O A T E I O p o u s E p U e jd o a d A ) A 3 p a d s ) s a a n e a r I a p u r S u r p e l L A n g P E N U ) e n u o d J o 3 d A L n N [ e u o n o N s u o n e s y p a d s U 0 D ) a n e A 8 T N N W I X G E q E Q I E S I Y S : w E N B Y q U s I A E F U I q I I Y Y S n o y L J 0 p 2 0 1 q ( 9 6 2 0 8 2 7 0 * N I Q ) 9 2 0 ‘2 z z 1 o q u i s i :d aa rs e q B I E P O P E A : 3 0 8 [ d Shree Saibaba Exim Private Limited 9 Floor, Galay Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020 CIN - U51101GJ2013PTC077088 Email ID - s@%gbuximlfl@nfl.gm Date: 22/09/2026 To, To, The Department of Corporate Service, The Board of Directors, BSE Limited, EVEXIA LIFECARE LIMITED, Phiroze Jeejeebhoy Tower, Vill: Tundao, Tal: Salvi Vadodara-391775, Dalal Street, Mumbai-400 001. Gujarat Scrip Code: 524444 Dear Sir/Madam, Subject: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 This is with reference to the disclosure enclosed herewith as required to be made upon purchase of shares of Evexia Lifecare Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Kindly take the above information on record. Thanking you, Yours faithfully,/ Name: Shfee Saibaba Exim Private Limited Through Artiben Jayeshbhai Thakkar Director (DIN: 02480296) CC To: EVEXIA LIFECARE LIMITED (For information and record) Vill : Tundao, Tal: Salvi Vadodara-391775, Gujarat Encl: as above Annexure 1 Disclosures under Regulation 29(2) of SEBI (Substantial A ition of Shares and Takeovers Regulations, 2011 Name of the Target Company (TC) EVEXIA LIFECARE LIMITED Name(s) of the acquirer/SeHer and Persons Acting in M/s. Shree Saibaba Exim Private Limited Concert (PAC) with the acquirer/Seler Whether the acquirer/Seller belongs to | Yes (Promoter Group) Promoter/Promoter group Name(s) of the Stock Exchange(s) where the shares of | BSE Limited TC are Listed Details of the acquisition / dispesat as follows Number % w.r.t. total % w.r.t. share/voting total diluted capital share/voting wherever capital of applicable(*) | the TC (**) Before the acquisition / dispesal under consideration, holding of : a) Shares carrying voting rights 11,34,67,585 6.044% 6.044% b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) 0 0.00% 0.00% ¢) Voting rights (VR) otherwise than by shares 0 0.00% 0.00% d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) 0 0.00% 0.00% Total (a+b+c+d) 11,34,67,585 6.044% 6.044% Details of acquisition/sale a) Shares carrying voting rights acquired/seld 14,45,000 0.076% 0.076% b) VRs acquired/sold otherwise than by shares 0 0.00% 0.00% ¢) Warrants/convertible securities/any other 0 0.00% 0.00% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked/released by the 0 0.00% 0.00% acquirer/seller Total (a+b+c+d) 14,45,000 0.076% 0.076% After the acquisition/sale, holding of: a) Shares carrying voting rights b) Shares encumbered with the acquirer/seller 0.00% 0.00% ¢) VRs otherwise than by shares 0.00% 0.00% d) Warrants/convertible securities/any other 0.00% 0.00% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after aequisition/sale Total (a+b+c+d) 11,49,12,585 6.121% 6.121% Mode of acquisition/sale (e.g. open market / eff-market Open Market +—publie—issue—/—rights—issue /preferential-allotment/ inter-se-transeftce.r) Date of acquisition / sale-ef-shares—-—VRordate—of September 22, 2026 receipt-of-intimation-of allotment-of shares, whichever is applicable Equity share capital / total vo [Showing first 8,000 characters — download PDF for full document]